Metformin: evidence from preclinical and clinical studies for potential novel applications in cardiovascular disease
Author:
Affiliation:
1. Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK
2. Division of Cellular Medicine, University of Dundee, Dundee, UK
3. Division of Population Health and Genomics, University of Dundee, Dundee, UK
Funder
Tenovus
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13543784.2023.2196010
Reference85 articles.
1. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
2. Update on the treatment of type 2 diabetes mellitus
3. The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study
4. Metformin Protects the Heart Against Hypertrophic and Apoptotic Remodeling After Myocardial Infarction
5. Cardioprotection by Metformin: Beneficial Effects Beyond Glucose Reduction
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The causal relationship between metformin and bone mineral density: A Two- Sample Mendelian randomization study;2024-08-16
2. Overexpression of miR-199b-5p in Colony Forming Unit-Hill’s Colonies Positively Mediates the Inflammatory Response in Subclinical Cardiovascular Disease Model: Metformin Therapy Attenuates Its Expression;International Journal of Molecular Sciences;2024-07-25
3. Metformin Monotherapy With and Without Lifestyle Changes Affects Anthropometric Parameters, Blood Pressure, Blood Glucose, and Lipid Profile in Indian Patients With Newly Diagnosed Type 2 Diabetes;Cureus;2024-06-11
4. Unraveling genetic causality between metformin and myocardial infarction on the basis of Mendelian randomization;Frontiers in Endocrinology;2024-05-03
5. Formulation, characterization and evaluation of vildagliptin and metformin combined tablets;Pharmacia;2024-04-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3